Commission Implementing Regulation (EU) 2025/1879 of 16 September 2025 renewing the approval of the low-risk active substance rape seed oil in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011

Renewal of the approval of the active substance

Article 1

The approval of the active substance rape seed oil, as specified in Annex I to this Regulation, is renewed, subject to the conditions laid down in that Annex.

Amendment to Implementing Regulation (EU) No 540/2011

Article 2

The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with Annex II to this Regulation.

Entry into force and date of application

Article 3

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union . It shall apply from 1 November 2025.

ANNEX ISupplementary provisions

ANNEX I Common Name, Identification Numbers IUPAC Name Purity  ( 1 ) Date of approval Expiration of approval Specific provisions Rape seed oil CAS No: 8002-13-9 (Rape seed oil) 93165-31-2 (Rape seed oil – low erucic acid) CIPAC No: Not available Rape seed oil The purity complies with the European Pharmacopeia 7.0 and Deutscher Arzneimittel-Codex 1986, 6. Erg. 1994 and ph. Eur. 5, 2005. The active substance is a mixture of triglycerides of fatty acids and the mode of action is mechanical rather than chemical: 100 % of the technical active substance is considered as an active substance. The specifications are based on the composition as fatty acids and some physical and chemical parameters. The impurity erucic acid shall not exceed 2 %. 1 November 2025 31 October 2040 For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the renewal report on rape seed oil, and in particular Appendices I and II thereto, shall be taken into account. In this overall assessment Member States shall pay particular attention to the protection of aquatic organisms, honey bees, and non-target arthropods. Conditions of use shall include risk mitigation measures, where appropriate. ( 1 )   Further details on the identity and specification of the active substance are provided in the renewal report.

ANNEX IISupplementary provisions

ANNEX II The Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: (1) in Part A, entry 242 on rape seed oil is deleted; (2) in Part D, the following entry is added: No Common Name, Identification Numbers IUPAC Name Purity  ( 1 ) Date of approval Expiration of approval Specific provisions ‘54 Rape seed oil CAS No: 8002-13-9 (Rape seed oil) 93165-31-2 (Rape seed oil – low erucic acid) CIPAC No: Not available Rape seed oil The purity complies with the European Pharmacopeia 7.0 and Deutscher Arzneimittel-Codex 1986, 6. Erg. 1994 and ph. Eur. 5, 2005. The active substance is a mixture of triglycerides of fatty acids and the mode of action is mechanical rather than chemical: 100 % of the technical active substance is considered as an active substance. The specifications are based on the composition as fatty acids and some physical and chemical parameters. The impurity erucic acid shall not exceed 2 %. 1 November 2025 31 October 2040 For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the renewal report on rape seed oil, and in particular Appendices I and II thereto, shall be taken into account. In this overall assessment Member States shall pay particular attention to the protection of aquatic organisms, honey bees, and non-target arthropods. Conditions of use shall include risk mitigation measures, where appropriate.’ ( 1 )   Further details on the identity and specification of the active substance are provided in the renewal report.